Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Daniel Herrera-Fernández"'
Autor:
Carlos E. Espinosa-de la Garza, Luis F. Flores-Ortiz, Víctor R. Campos-García, Emilio Medina-Rivero, Jesús Padilla-Calderón, Carlos A. López-Morales, Eleuterio Benites-Zaragoza, Armando Jiménez-Miranda, Daniel Herrera-Fernández, Néstor O. Pérez
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 132:133-140
Complex pharmaceuticals are in demand of competent analytical methods able to analyze charge heterogeneity as a critical quality attribute (CQA), in compliance with current regulatory expectations. A notorious example is glatiramer acetate (GA), a co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::383160b012f8fd48a2bcf499fee8fed4
https://doi.org/10.1016/j.jpba.2016.10.002
https://doi.org/10.1016/j.jpba.2016.10.002
Autor:
Luis Vallejo-Castillo, Isabel Gracia-Mora, Néstor O. Pérez, Leslie Muñoz-García, Rodolfo Salazar-Ceballos, Luis F. Flores-Ortiz, Daniel Herrera-Fernández, Carlos E. Espinosa-de la Garza, Lenin Pavón, Sonia Mayra Pérez-Tapia, Emilio Medina-Rivero, Víctor R. Campos-García, Sandra Avila, German González
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Glatiramer Acetate (GA) is an immunomodulatory medicine approved for the treatment of multiple sclerosis, whose mechanisms of action are yet to be fully elucidated. GA is comprised of a complex mixture of polypeptides with different amino acid sequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ad775b469704d35eaac7912e027350f
https://doi.org/10.1038/s41598-017-12416-1
https://doi.org/10.1038/s41598-017-12416-1